Infinity Pharmaceuticals Inc (OTC Pink - Current Information:INFI)
| 0.016 Delayed Data As of Sep 29 |  -0.0008 / -4.76%Today’s Change | 0.01 Today|||52-Week Range 1.30 | -97.12% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 188.2M | 75.2M | 34.6M | 48.6M | |
| Short Term Investment Cash | -119.2M | -114.1M | -39.5M | 14.0M | ||
| Cash & Short Term Investments | 245.2M | 93.2M | 57.6M | 58.6M | ||
| Receivables | Receivables | 1.2M | 0.00 | 0.00 | 0.00 | |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Current Assets | Prepaid Expenses | 6.9M | 3.4M | 563.0K | 641.0K | |
| Other Current Assets | 1.4M | 5.0M | 214.0K | 586.0K | ||
| Current Assets | 254.7M | 101.7M | 58.4M | 59.8M | ||
| Total Assets | Property, Plant and Equipment - Gross | 49.1M | 29.3M | 1.8M | 1.8M | |
| Depreciation | -20.9M | -5.9M | -1.6M | -1.8M | ||
| Other Assets | 2.4M | 41.0K | 748.0K | 369.0K | ||
| Total Assets | 288.8M | 125.7M | 59.4M | 60.2M | ||
| Liabilities | Accounts Payable | 9.6M | 2.4M | 459.0K | 1.2M | |
| Short Term Debt | 416.0K | 442.0K | 6.0M | 0.00 | ||
| Accrued Expenses | 15.6M | 15.6M | 3.1M | 3.9M | ||
| Other Current Liabilities | 51.3M | 15.6M | 3.1M | 3.9M | ||
| Other Liabilities | 70.1M | 23.9M | 11.6M | 7.7M | ||
| Total Liabilities | Long Term Debt | 19.6M | 19.1M | 0.00 | 0.00 | |
| Other Liabilities | 5.1M | 189.0K | 28.0K | 38.0K | ||
| Total Liabilities | 190.3M | 43.2M | 11.6M | 7.8M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 98.6M | 82.5M | 47.7M | 52.5M | ||
| Total Shareholder Equity | 98.6M | 82.5M | 47.7M | 52.5M | ||
| Share Information | Common Shares Outstanding | 49.3M | 50.4M | 50.8M | 56.9M | |
| Addtl. Info. | No data currently available for this section. | |||||
